NL8700927A - Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing. - Google Patents

Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing. Download PDF

Info

Publication number
NL8700927A
NL8700927A NL8700927A NL8700927A NL8700927A NL 8700927 A NL8700927 A NL 8700927A NL 8700927 A NL8700927 A NL 8700927A NL 8700927 A NL8700927 A NL 8700927A NL 8700927 A NL8700927 A NL 8700927A
Authority
NL
Netherlands
Prior art keywords
interferon
antibodies
lps
reactions
mice
Prior art date
Application number
NL8700927A
Other languages
English (en)
Dutch (nl)
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Priority to NL8700927A priority Critical patent/NL8700927A/nl
Priority to PCT/BE1988/000011 priority patent/WO1988007869A2/fr
Publication of NL8700927A publication Critical patent/NL8700927A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8700927A 1987-04-16 1987-04-16 Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing. NL8700927A (nl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL8700927A NL8700927A (nl) 1987-04-16 1987-04-16 Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.
PCT/BE1988/000011 WO1988007869A2 (fr) 1987-04-16 1988-04-18 ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8700927A NL8700927A (nl) 1987-04-16 1987-04-16 Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.
NL8700927 1987-04-16

Publications (1)

Publication Number Publication Date
NL8700927A true NL8700927A (nl) 1988-11-16

Family

ID=19849883

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8700927A NL8700927A (nl) 1987-04-16 1987-04-16 Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.

Country Status (2)

Country Link
NL (1) NL8700927A (fr)
WO (1) WO1988007869A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8905400D0 (en) * 1989-03-09 1989-04-19 Jonker Margreet Medicaments
DK195089A (da) * 1989-04-20 1990-10-21 Morten Bagge Hansen Regulatoriske proteiner
IT1231727B (it) * 1989-08-11 1991-12-21 Enrico Savoldi Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
EP1137766B1 (fr) 1998-12-09 2005-09-28 Protein Design Labs, Inc. Usage des anticorps il-12 pour le traitement du psoriasis humain
US7335743B2 (en) 2002-10-16 2008-02-26 Amgen Inc. Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088540A3 (fr) * 1982-02-22 1984-10-17 Biogen, Inc. Séquences d'ADN, molécules d'ADN recombinant et procédure pour la production de polypeptides semblables à l'interféron humain immun

Also Published As

Publication number Publication date
WO1988007869A2 (fr) 1988-10-20
WO1988007869A3 (fr) 1988-11-17

Similar Documents

Publication Publication Date Title
MANNICK et al. Prolongation of allograft survival by an alpha globulin isolated from normal blood
AU2004216176B2 (en) Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
Deitch Multiple organ failure pathophysiology and potential future therapy
Heremans et al. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide.
Zurier et al. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice
US6660266B1 (en) Reversal of proinflammatory response by ligating the macrophage FcγRI receptor
Nakane et al. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection
US4695459A (en) Method of treating autoimmune diseases that are mediated by Leu3/CD4 phenotype T cells
AP660A (en) A method of treatment of parasitic infection using IgE antagonists.
US4980160A (en) Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases
JPH04505010A (ja) 免疫調節障害の処置のための薬剤生成物
Gamble et al. Experimental uveitis: I. The production of recurrent immunologic (Auer) uveitis and its relationship to increased uveal vascular permeability
AU2020353038A1 (en) Use of CD200 protein and CD200 fusion protein in preparing a drug for treating psoriasis
Borel et al. T and B cell in hapten-specific carrier-determined tolerance.
NL8700927A (nl) Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.
Embling et al. The structural requirements for immunoglobulin aggregates to localize in germinal centres.
US20070032426A1 (en) Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
WO1999013909A1 (fr) Inhibiteurs de neovascularisation corneenne
Bergese et al. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL4.
US6315999B1 (en) Pharmaceutical product for the treatment of sepsis
AU651320B2 (en) Pharmaceutical product for the treatment of sepsis
JP2005516907A (ja) 霊長類ｉｆｎ−ガンマ結合分子の使用
Poralla et al. Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro
Li et al. Experimental smooth muscle antibodies.
Amagai et al. The effect of Ribavirin and Rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed